Delivery Order SPE2DE21D7020-SPE2D625F3LPU
- Not listed
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $26,532.60 to Boston Scientific Corp for agent drug-coated balloon medical devices. The contract, issued on August 18, 2025, carries a fixed-price pricing structure with economic price adjustment provisions and has an ultimate completion date of August 25, 2025. This delivery order represents a continuation of Boston Scientific's role as a key supplier of specialized cardiovascular intervention equipment to...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp for drug-coated balloons on September 10, 2025, with a contract ceiling value of $6,175 and an ultimate completion date of September 17, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough,...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $18,918.66 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on June 27, 2025. The contract is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of July 7, 2025. The place of performance is located in Marlborough, MA, where Boston Scientific...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $21,014.55 to Boston Scientific Corp for agent drug-coated balloons, with an ultimate completion date of July 30, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at the company's facility in Marlborough, Massachusetts, where Boston Scientific manufactures...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp for agent drug-coated balloons with a ceiling value of $6,175. The contract is a fixed-price agreement with economic price adjustment provisions, with an ultimate completion date of August 21, 2025. This delivery order was not set aside for any specific business category and will be performed at Boston Scientific's Marlborough, Massachusetts facility. As a prime contractor, Boston Scientific is...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $41,639.42 to Boston Scientific Corp for agent drug-coated balloons, with an ultimate completion date of September 22, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The award leverages Boston Scientific's established capabilities as a major supplier of advanced cardiovascular...
- Boston Scientific Corp has been awarded a delivery order valued at $8,150.20 for agent drug-coated balloons under a Defense Health Agency Medical Supply Chain contract. The award, issued on September 16, 2025, with a completion date of September 19, 2025, utilizes fixed-price pricing with economic price adjustment terms. The contract carries no set-aside designation, indicating open competition in the federal marketplace. Performance will be executed at Boston Scientific's Marlborough,...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F3LPUDelivery Order
The Defense Health Agency's Medical Supply Chain has awarded a delivery order to Boston Scientific Corp for agent drug-coated balloons, with a ceiling value of approximately $19.9K and an ultimate completion date of September 22, 2025. This fixed-price contract with economic price adjustment provisions was awarded on September 15, 2025, with no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's Marlborough, Massachusetts facility, where the company manufactures its portfolio of cardiovascular intervention devices and medical technologies. Boston Scientific, a global medical technology leader headquartered in Massachusetts, serves as a major federal contractor supplying advanced medical devices to the Department of Veterans Affairs, Defense Health Agency, and Defense Logistics Agency. The company's extensive federal contract portfolio includes cardiovascular devices, interventional equipment, neurostimulation systems, and diagnostic tools. This delivery order for drug-coated balloons represents a continuation of Boston Scientific's role as a critical supplier of specialized cardiovascular technologies to the federal healthcare system, leveraging the company's established capabilities in developing and manufacturing innovative medical devices for federal healthcare agencies' evolving needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.9k | 9/15/25 |